Rundu Pharmaceuticals Plans to Expand Nicotine Products Overseas

Jan.23

Investors inquire about potential collaboration with Swedish match company and US nicotine pouch sales for Ruando Group (002923.SZ).

Recently, an investor raised questions on the interactive platform asking whether Runto Corporation (002923.SZ) is collaborating with Swedish Match AB and whether they have plans to register their brand to sell nicotine pouch products in the United States.

In response to this, Runto Pharmaceuticals stated that the quality of the bioalkaloids (nicotine) produced by its wholly-owned subsidiary Runto Pharmaceuticals (Jingmen) Co., Ltd. has been widely recognized and has achieved commercial sales. Nicotine products can be applied in various fields such as pharmaceuticals, pesticides, e-cigarettes, nicotine pouches, and nicotine patches, with a wide range of applications. The company will actively understand the relevant domestic and foreign market access rules, strive to gain more commercial cooperation opportunities, and provide better returns for investors.

References:

[1] 公司有没有计划自己注册品牌在美国销售尼古丁袋产品？

Also Read:

[1] Production and Applications of Nicotine by Rundu International

[2] E-cigarette Company Rundu Stock's Performance and Roadshow

#Asia #China #Nicotine pouches #Major companies

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Echo Guo: The Accumulating Risks Behind the Surge in Chinese Vape Exports to the U.S.

Chinese vape exports to the U.S. jumped from about 2.2 million kg in June to 14.8 million kg in October 2025, despite tougher enforcement, the Washington Examiner reported. 2Firsts finds the surge reflects delayed bulk shipments, not demand recovery. With U.S. inventory exceeding 160 million devices and distributors paying ~10% upfront, cash-flow stress has shifted to Chinese manufacturers, and discounted stock is spilling into other markets.

Dec.14 by Echo Duo

Bangladesh Approves Philip Morris Factory for Nicotine Pouches, Sparks Controversy: Regulator Says It’s “Completely Legal”

Philip Morris Bangladesh Limited (PMBL) has received approval to invest USD 5.82 million in a nicotine pouch factory in Narayanganj. Regulators say the project is legal under existing laws, while health groups argue it breaches a 2016 Supreme Court order and poses youth addiction risks.

Nov.07 by 2FIRSTS.ai

Trump Signs H.R.5371: FDA to Deploy $200 Million for ENDS Enforcement

President Donald Trump signed the Continuing Appropriations Act, 2026 (H.R.5371) on November 12, Section 772 of Part B—the Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act (S.2256)—requires the FDA to allocate no less than $200 million in tobacco user fees to enforce regulations against illegal e-cigarettes, vapes, and other ENDS products. At least $2 million of this funding supports a federal multi-agency task force targeting products originating from the China.

Nov.14 by 2FIRSTS.ai

Kentucky to Require Tobacco and Vape Retailers to Be Licensed Starting January 2026

The Kentucky Public Protection Cabinet has reminded all businesses selling tobacco, nicotine, and vapor products that they must be licensed by the Kentucky Department of Alcoholic Beverage Control (ABC) by January 1, 2026. The requirement stems from Senate Bill 100, signed into law by Governor Andy Beshear on March 24, 2025, aimed at strengthening youth protection and enforcing compliance against unlicensed sales.